Vishal Mega Mart Employee Stock Options

Vishal Mega Mart Earnings Call Transcript: Key Takeaways

Vishal Mega Mart delivered 14% revenue growth despite a 3-4% festive shift impact. Management remains aggressive on store expansion but faces short-term operating deleverage from minimum wage hikes and festive timing.

Vishal Mega Mart Investor Presentation: Key Takeaways

Vishal Mega Mart reported Q2FY27 revenue of ₹3,398.5 Cr (up 14% YoY) with Adj. PAT of ₹172 Cr. Strategy focuses on store expansion and omni-channel growth via the 'Belong & Co' pilot.

Vishal Mega Mart Results Update

Vishal Mega Mart's Q2FY27 revenue rose 14% to ₹3,398.5 Cr; PAT ₹157.9 Cr. H1FY27 revenue hit ₹7,125.5 Cr, adding 49 net stores.

total store count

844 stores

Vishal Mega Mart Q2 FY27 Results: Net Profit ₹157.9 Cr, Up 3.7% YoY

Vishal Mega Mart Ltd reported revenue from operations of ₹3,398 Cr (+14.0% YoY) and net profit of ₹157.9 Cr (+3.7% YoY) for Q2 FY27.

Key figure

Net profit ₹157.9 Cr · +3.7% YoY

Vishal Mega Mart Board Meeting Date

Vishal Mega Mart scheduled its Board meeting for 21 Oct 2026 to approve Q1/H1 results. The trading window remains closed until 48 hours post-announcement.

Vishal Mega Mart Other Announcement

Vishal Mega Mart Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Maxvolt Energy Industries Employee Stock Options

Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.

Execution

Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date